Literature DB >> 7075937

25-Hydroxyvitamin D3 treatment of bone disease in primary biliary cirrhosis.

S B Arnaud.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7075937

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  6 in total

1.  Does "hepatic osteodystrophy" differ from peri- and postmenopausal osteoporosis? A histomorphometric study.

Authors:  M S Shih; C Anderson
Journal:  Calcif Tissue Int       Date:  1987-10       Impact factor: 4.333

Review 2.  Treatment in primary biliary cirrhosis.

Authors:  N D Finlayson
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-10

3.  Hepatic osteodystrophy: does the osteoprotegerin/receptor activator of nuclear factor-kB ligand system play a role?

Authors:  A Gaudio; A Lasco; N Morabito; M Atteritano; C Vergara; A Catalano; W Fries; A Trifiletti; N Frisina
Journal:  J Endocrinol Invest       Date:  2005-09       Impact factor: 4.256

4.  The heterogeneity of bone disease in cirrhosis: a multivariate analysis.

Authors:  Bronwyn A L Crawford; C Kam; A J Donaghy; G W McCaughan
Journal:  Osteoporos Int       Date:  2003-09-19       Impact factor: 4.507

Review 5.  Hypovitaminosis D: Is It Time to Consider the Use of Calcifediol?

Authors:  Roberto Cesareo; Alberto Falchetti; Roberto Attanasio; Gaia Tabacco; Anda Mihaela Naciu; Andrea Palermo
Journal:  Nutrients       Date:  2019-05-06       Impact factor: 5.717

Review 6.  Definition, Assessment, and Management of Vitamin D Inadequacy: Suggestions, Recommendations, and Warnings from the Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS).

Authors:  Francesco Bertoldo; Luisella Cianferotti; Marco Di Monaco; Alberto Falchetti; Angelo Fassio; Davide Gatti; Luigi Gennari; Sandro Giannini; Giuseppe Girasole; Stefano Gonnelli; Nazzarena Malavolta; Salvatore Minisola; Mario Pedrazzoni; Domenico Rendina; Maurizio Rossini; Iacopo Chiodini
Journal:  Nutrients       Date:  2022-10-06       Impact factor: 6.706
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.